Skip to main content
Clinical Trials/NL-OMON20229
NL-OMON20229
Recruiting
N/A

Patient reported outcomes in high risk and advanced melanoma patients

one, investigator initiated0 sites300 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
High-risk (resectable stage III) or advanced (stage IV and unresectable stage III) melanoma
Sponsor
one, investigator initiated
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
one, investigator initiated

Eligibility Criteria

Inclusion Criteria

  • Adults of 18 years and older; Melanoma patients indicated to receive treatment with immune checkpoint\-inhibitors, according to the clinical guidelines; Written informed consent to participate in the study.

Exclusion Criteria

  • Insufficient understanding of the Dutch or English language; Inclusion in experimental clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials